about
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A miceReversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015Hemophilia Care in the Pediatric Age.Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.Engineering less immunogenic and antigenic FVIII proteins.Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.Identification of Aggregates in Therapeutic Formulations of Recombinant Full-Length Factor VIII Products by Sedimentation Velocity Analytical Ultracentrifugation.
P2860
Q27321626-E92F872F-5C49-48E6-8C64-F3A3EA786490Q28072261-7E2CB2B9-A4B5-4CC8-B504-0E629546C964Q33737259-361DF6F2-CC34-4749-A695-6EF9A94CCDBDQ35885551-E72CE169-C089-4C0A-98A7-764C9B3E5DC8Q38632876-2DA58E1B-1C06-4AEE-B740-75A378306E6CQ45855530-6FD7FF9C-060C-4DF2-9AA1-93B06E99ABF4Q45875342-4F0DF0A7-7E76-4563-94DD-3C2FA5EB1878
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genetic risk factors for inhibitors in haemophilia A.
@en
type
label
Genetic risk factors for inhibitors in haemophilia A.
@en
prefLabel
Genetic risk factors for inhibitors in haemophilia A.
@en
P2860
P356
P1476
Genetic risk factors for inhibitors in haemophilia A.
@en
P2093
Edit Bardi
Jan Astermark
P2860
P356
10.1111/EJH.12495
P478
94 Suppl 77
P577
2015-02-01T00:00:00Z